Model of care | ||||
---|---|---|---|---|
ANC | TC | PRIVATE | ||
(2007–2010) | (2009–2011) | (2009–2011) | ||
N = 84 | N = 101 | N = 101 | p valuea | |
Maternal outcomes | Number (%) | Number (%) | Number (%) | |
Antenatal admission | 46 (55) | 60 (59) | 49 (49) | 0.3 |
Complications of pregnancy | ||||
Placenta praevia | 3 (4) | 0 (0) | 2 (2) | 0.18 |
Antepartum haemorrhage ≥ 20 weeks | 6 (7) | 3 (3) | 3 (3) | 0.28 |
Hypertensive disorder of pregnancy | 11 (13) | 13 (13) | 13 (13) | 1 |
Gestational diabetes | 7 (8) | 9 (9) | 5 (5) | 0.51 |
Threatened premature labour | 18 (21) | 14 (14) | 6 (6) | 0.008 |
PROM | 11 (13) | 13 (13) | 8 (8) | 0.43 |
Antenatal steroids | 27 (32) | 23 (23) | 47 (47) | 0.002 |
Labour | 40 (48) | 54 (54) | 35 (35) | 0.02 |
Labour induced or augmented | 27 (35) | 44 (44) | 24 (24) | 0.01 |
Mode of birth | ||||
Caesarean both twins | 56 (67) | 54 (54) | 74 (73) | 0.01 |
Vaginal birth both twinsb | 25 (30) | 45 (45) | 25 (25) | 0.008 |
Caesarean second twin after vaginal birth Twin 1 | 3 (4) | 2 (2) | 2 (2) | 0.73 |
Any Caesarean | 59 (70) | 56 (55) | 76 (76) | 0.008 |
Epidural use in labour | 23 (56) | 37 (69) | 26 (74) | |
(Total N = 40) | (Total N = 54) | (Total N = 35) | 0.29 | |
PPH 500–999 ml | 21 (25) | 28 (28) | 20 (20) | 0.41 |
PPH ≥ 1000 ml | 5 (6) | 10 (10) | 11 (11) | 0.74 |
Maternal length of stay | ||||
Total admission length (days), median (IQR) | 8.0 (6–12) | 7 (6–9) | 7 (5–9) | 0.001 |
Total admission length ≥ 7 days, n (%) | 58 (69) | 52 (52) | 64 (63) | 0.04 |
Maternal postnatal stay (days), median (IQR) | 5.8 (4.5–7.0) | 5.1 (4.6–6.1) | 5.7 (4.9–6.8) | 0.004 |
Maternal postnatal stay ≥ 5 days, n (%) | 55 (65) | 60 (59) | 70 (69) | 0.33 |